Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2023-11-22 15:01:20）
  Furukawa Tetsuya
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05 Link
2. Original article　 Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05
3. Original article　 Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
4. Original article　 TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report. 2022/07
5. Original article　 Serum B cell activating factor(BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis. 2022/12
■ Presentation
1. Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity. （Poster presentation，General Lecture） 2019/06/13
2. Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis. （Poster presentation，General Lecture） 2019/11/11
3. Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis. （Poster presentation，General Lecture） 2019/11/11
4. A usability survey of wrist mounted disposable heat pad on raynaud’s phenomenon in patients with connective tissue diseases. （Poster presentation，General Lecture） 2020/07/03
5. The baseline soluble GP130 is associated with the response of rheumatoid arthritis patients to sarilmab. （Poster presentation，General Lecture） 2020/07/03
6. Circulating cell free DNA as a biomarker in Eosinophilic granulomatosis with polyangiitis. （Web announcement，Symposium/Workshop/Panel Discussion） 2020/09/17
7. Wrist mounted disposable heat pad is a highly practical heating method for connective tissue diseases patients presenting with Raynaud’s Phenomenon. 22nd Asia-Pacific League of Associations for Rheumatology
Virtual Congress (APLAR2020) （Web announcement，General Lecture） 2020/10/24
8. Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE. （Newspaper announcement） 2021/06/02
9. Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab. （Poster presentation，General Lecture） 2021/08/28
10. Plasma cell-free DNA is a useful biomarker for tocilizumab therapy in rheumatoid arthritis. （Poster presentation，General Lecture） 2021/11/08
11. Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients. （Newspaper announcement） 2022/06/01
12. The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs. （Newspaper announcement） 2022/06/01
13. YKL-40-mediated Inflammatory pathogenesis common to polymyositis/dermatomyositis. （Poster presentation，General Lecture） 2022/10/14
14. Eosinophil activation as a biomarker for discriminating active and remission phase in ANCA-Associated vasculitis. （Poster presentation，General Lecture） 2023/11/14
15. Comparative evaluation of CLIA and EIA assays for the Detection of Antiphospholipid Antibodies. （Poster presentation，General Lecture） 2023/12
16. Similar effect of co-administration of methotrexate and folic acid for the treatment of rheumatoid arthritis compared with separate administration. （Poster presentation，General Lecture） 2023/12
Display 5 items
Display all(16)
mail